| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3383983 | Reumatología Clínica | 2006 | 10 Pages |
Abstract
Currently, there is insufficient evidence to confirm the real efficacy of botulinum toxin A and B in the treatment of MPS. Given the high cost of botulinum toxin, long-term high quality studies are required.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
Claudia Alejandra Pereda, Jacqueline Usón Jaeger, Loreto Carmona,